E
Emilio Moreno
Researcher at GE Healthcare
Publications - 5
Citations - 2744
Emilio Moreno is an academic researcher from GE Healthcare. The author has contributed to research in topics: Dementia with Lewy bodies & Spect imaging. The author has an hindex of 4, co-authored 5 publications receiving 1876 citations. Previous affiliations of Emilio Moreno include United States Department of Veterans Affairs & North Essex Partnership University NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith,Bradley F. Boeve,Dennis W. Dickson,Glenda M. Halliday,John-Paul Taylor,Daniel Weintraub,Dag Aarsland,Dag Aarsland,James E. Galvin,Johannes Attems,Johannes Attems,Clive Ballard,Clive Ballard,Ashley Bayston,Ashley Bayston,Thomas G. Beach,Thomas G. Beach,Frédéric Blanc,Nicolaas Bohnen,Nicolaas Bohnen,Nicolaas Bohnen,Laura Bonanni,Laura Bonanni,Jose Bras,Jose Bras,Patrik Brundin,Patrik Brundin,David J. Burn,David J. Burn,Alice Chen-Plotkin,John E. Duda,Omar M. A. El-Agnaf,Howard Feldman,Tanis J. Ferman,Dominic Ffytche,Hiroshige Fujishiro,Douglas Galasko,Jennifer G. Goldman,Stephen N. Gomperts,Neill R. Graff-Radford,Lawrence S. Honig,Lawrence S. Honig,Alex Iranzo,Alex Iranzo,Alex Iranzo,Kejal Kantarci,Daniel I. Kaufer,Walter Kukull,Virginia M.Y. Lee,James B. Leverenz,James B. Leverenz,Simon J.G. Lewis,Carol F. Lippa,Carol F. Lippa,Angela Lunde,M Masellis,M Masellis,M Masellis,Eliezer Masliah,Pamela J. McLean,Brit Mollenhauer,Brit Mollenhauer,Thomas J. Montine,Thomas J. Montine,Emilio Moreno,Emilio Moreno,Emilio Moreno,Etsuro Mori,Etsuro Mori,Etsuro Mori,Melissa E. Murray,John T. O'Brien,John T. O'Brien,Sotoshi Orimo,Sotoshi Orimo,Ronald B. Postuma,Ronald B. Postuma,Shankar Ramaswamy,Shankar Ramaswamy,Owen A. Ross,David P. Salmon,David P. Salmon,Andrew B. Singleton,Andrew B. Singleton,Angela Taylor,Angela Taylor,Alan Thomas,Pietro Tiraboschi,Jon B. Toledo,John Q. Trojanowski,Debby W. Tsuang,Zuzana Walker,Zuzana Walker,Masahito Yamada,Masahito Yamada,Kenji Kosaka +95 more
TL;DR: The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade.
Journal ArticleDOI
Accuracy of DaTSCAN (123I-ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-Year follow-up of an open-label study
TL;DR: 2‐year follow‐up of the CUPS study aimed to validate the results of DaTSCAN imaging and to ascertain whether a second scan could minimize any residual diagnostic uncertainty among those with an inconclusive diagnosis.
Journal ArticleDOI
Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study
Zuzana Walker,Emilio Moreno,Alan J. Thomas,Fraser Inglis,Naji Tabet,Michael Rainer,Gilberto Pizzolato,Alessandro Padovani +7 more
TL;DR: Installing a single photon emission computed tomography scan in patients with possible DLB significantly contributed to a more certain diagnosis, proving to be a useful adjunct in the work-up of patients with possibly DLB.
Journal ArticleDOI
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
Zuzana Walker,Emilio Moreno,Alan Thomas,Fraser Inglis,Naji Tabet,Tim Stevens,Tim Whitfield,Dag Aarsland,Michael Rainer,Alessandro Padovani +9 more
TL;DR: There was no difference in the evolution of DLB clinical features over 6 months between cases with normal and abnormal imaging, and only parkinsonism and dopamine transporter imaging helped to differentiate DLB from non-DLB dementia.
Journal ArticleDOI
Impacto presupuestario del uso de un contraste isoosmolar frente a contrastes de baja osmolaridad en pacientes con alto riesgo de nefropatía inducida por contraste en el entorno hospitalario español
Eduardo Pinar,José M. de la Torre Hernández,Josepa Mauri,Francisco Picó,Rafael Ruiz,Ángel Luis de Francisco,Carmen Barrull,Emilio Moreno,Alexis Sampedro,Felipe Hernández +9 more
TL;DR: The budget impact of the use of iodixanol, an isosmolar CM compared with low osmolar contrast media (LOCM) in high-risk patients undergoing coronary angiography (AC) or percutaneous coronary intervention (PCI) in Spanish hospitals is estimated.